Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc for Prevention of Anti-EGFR Antibody-Induced Paronychia
jRCTs031250776Recruiting
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of zinc in colorectal cancer (CRC) (2 arms). Primary endpoint: Incidence of paronychia at 8 weeks. Started Mar 2026; status: recruiting.
02
Drugs
zinc
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs031250776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250776.